Doses were increased if serum ferritin levels increased by ≥1000 ng/mL above baseline on two consecutive visits or were >2500 ng/mL (changed to >1000 ng/mL in amendment 4) without a decreasing trend (or >500 ng/mL with an increasing trend, added in amendment 4).
← all excerpts
Importance of optimal dosing ≥ 30 mg/kg/d during deferasirox treatment: 2.7-yr follow-up from the ESCALATOR study in patients with β-thalassaemia.
1
—
—